GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Capital Reinvestment Ratio
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Capital Reinvestment Ratio of 0.32x as of September 2020, meaning it reinvests 0% of its operating cash flow (Rs1.23 Billion) in capital expenditures (Rs389.75 Million). See how leveraged is GlaxoSmithKline Pharmaceuticals Limited's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GlaxoSmithKline Pharmaceuticals Limited Capital Reinvestment Ratio (2005–2025)
This chart tracks GlaxoSmithKline Pharmaceuticals Limited's Capital Reinvestment Ratio across 21 annual periods. Check GlaxoSmithKline Pharmaceuticals Limited cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. For live market cap and broader valuation context, see GlaxoSmithKline Pharmaceuticals Limited (GLAXO) total market value.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | Rs12.90 Billion | Rs230.20 Million | ▼ -66.7% |
| 2024 | 0.05x | Rs5.82 Billion | Rs312.21 Million | ▼ -41.0% |
| 2023 | 0.09x | Rs4.84 Billion | Rs440.40 Million | ▲ +112.9% |
| 2022 | 0.04x | Rs8.11 Billion | Rs346.41 Million | ▼ -44.2% |
| 2021 | 0.08x | Rs5.78 Billion | Rs442.27 Million | ▼ -75.9% |
| 2020 | 0.32x | Rs4.90 Billion | Rs1.56 Billion | ▼ -56.4% |
| 2019 | 0.73x | Rs3.99 Billion | Rs2.91 Billion | ▼ -14.5% |
| 2018 | 0.85x | Rs4.73 Billion | Rs4.03 Billion | ▼ -33.9% |
| 2017 | 1.29x | Rs2.36 Billion | Rs3.04 Billion | ▼ -22.7% |
| 2016 | 1.67x | Rs1.39 Billion | Rs2.32 Billion | ▲ +245.5% |
| 2015 | 0.48x | Rs2.70 Billion | Rs1.30 Billion | ▲ +133.4% |
| 2014 | 0.21x | Rs2.81 Billion | Rs582.22 Million | ▲ +66.1% |
| 2013 | 0.12x | Rs3.14 Billion | Rs390.76 Million | ▼ -0.6% |
| 2012 | 0.13x | Rs3.36 Billion | Rs420.95 Million | ▲ +181.0% |
| 2011 | 0.04x | Rs4.79 Billion | Rs213.94 Million | ▼ -24.8% |
| 2010 | 0.06x | Rs5.12 Billion | Rs303.67 Million | ▼ -17.9% |
| 2009 | 0.07x | Rs3.30 Billion | Rs238.79 Million | ▲ +50.5% |
| 2008 | 0.05x | Rs3.19 Billion | Rs153.26 Million | ▼ -33.3% |
| 2007 | 0.07x | Rs2.59 Billion | Rs186.23 Million | ▲ +7.6% |
| 2006 | 0.07x | Rs3.49 Billion | Rs233.91 Million | ▲ +63.6% |
| 2005 | 0.04x | Rs2.29 Billion | Rs93.72 Million | — |